Evidence map›Paper›PMID 25300915›Full record

ArticleBioscience reports2015

A novel anti-proliferative role of HMGA2 in induction of apoptosis through caspase 2 in primary human fibroblast cells.

Xi Shi, Baoqing Tian, Wenlong Ma, Na Zhang, Yuehua Qiao, Xiaoxue Li, Yu Zhang, Baiqu Huang, Jun Lu

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Effects ofThe Journal of international medical research · 2022
    Article
  7. Article
  8. Review
  9. HMGA Genes and Proteins in Development and Evolution.International journal of molecular sciences · 2020
    Review
  10. Article
  11. MicroRNA Let-7d-3p Contributes to Cardiac Protection via Targeting HMGA2.International journal of molecular sciences · 2019
    Article
  12. Article
  13. Article
  14. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xi Shi*The Institute of Genetics and Cytology, Northeast Normal University, Changchun 130024, China.
Baoqing Tian*The Institute of Genetics and Cytology, Northeast Normal University, Changchun 130024, China.
Wenlong Ma*The Institute of Genetics and Cytology, Northeast Normal University, Changchun 130024, China.
Na Zhang*The Institute of Genetics and Cytology, Northeast Normal University, Changchun 130024, China.
Yuehua Qiao†The Institute of Audiology and Speech Science of Xuzhou Medical Collage, Xuzhou 221004, China.
Xiaoxue Li*The Institute of Genetics and Cytology, Northeast Normal University, Changchun 130024, China.
Yu Zhang*The Institute of Genetics and Cytology, Northeast Normal University, Changchun 130024, China.
Baiqu Huang*The Institute of Genetics and Cytology, Northeast Normal University, Changchun 130024, China.
Jun Lu*The Institute of Genetics and Cytology, Northeast Normal University, Changchun 130024, China.
Northeast Normal University · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The HMGA2 (high-mobility group AT-hook) protein has previously been shown as an oncoprotein, whereas ectopic expression of HMGA2 is found to induce growth arrest in primary cells. The precise mechanisms underlying this phenomenon remain to be unravelled. In the present study, we determined that HMGA2 was able to induce apoptosis in WI38 primary human cells. We show that WI38 cells expressing high level of HMGA2 were arrested at G2/M phase and exhibited apoptotic nuclear phenotypes. Meanwhile, the cleaved caspase 3 (cysteine aspartic acid-specific protease 3) was detected 8 days after HMGA2 overexpression. Flow cytometric analysis confirmed that the ratio of cells undergoing apoptosis increased dramatically. Concurrently, other major apoptotic markers were also detected, including the up-regulation of p53, Bax and cleaved caspase 9, down-regulation of Bcl-2; as well as release of cytochrome c from the mitochondria. We further demonstrate that the shRNA (small-hairpin RNA)-mediated Apaf1 (apoptotic protease activating factor 1) silencing partially rescued the HMGA2-induced apoptosis, which was accompanied by the decrease of cleaved caspase-3 level and a decline of cell death ratio. Our results also reveal that γH2A was accumulated in nuclei during the HMGA2-induced apoptosis along with the up-regulation of cleaved caspase 2, suggesting that the HMGA2-induced apoptosis was dependent on the pathway of DNA damage. Overall, the present study unravelled a novel function of HMGA2 in induction of apoptosis in human primary cell lines, and provided clues for clarification of the mechanistic action of HMGA2 in addition to its function as an oncoprotein.

Indexed as

ApoptosisCell ProliferationCaspase 2Cell Cycle CheckpointsCells, CulturedCytochromes cFibroblastsHMGA2 ProteinHumansMitochondriaCaspase 2Cytochromes cHMGA2 Protein

Identifiers

PMID25300915
PMCPMC4293904
OpenAlexW2129136790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.